Elective lung resection after treatment for COVID-19 pneumonia
Takashi Sakai, Yoko Azuma, Kotaro Aoki, Megumi Wakayama, Shion Miyoshi, Kazuma Kishi, Kazuhiro Tateda, Sakae Homma, Akira Iyoda, Takashi Sakai, Yoko Azuma, Kotaro Aoki, Megumi Wakayama, Shion Miyoshi, Kazuma Kishi, Kazuhiro Tateda, Sakae Homma, Akira Iyoda
Abstract
A 65-year-old man with coronavirus disease 2019 (COVID-19) was admitted to our hospital. Computed tomography detected bilateral pneumonia with a lung nodule suspicious for lung cancer. Lobectomy was performed 3 months after the treatment for COVID-19 without any complications. The surgical specimen revealed fibrosis below the pleura with a small collection of lymphocytes and intravascular hemorrhagic thrombosis, and no residual RNA was detected. This is the first report describing a surgical specimen after recovery from COVID-19 pneumonia, and suggests that elective thoracic surgery can be performed safely, depending on the patient's respiratory function, without infectious risk.
Keywords: COVID-19; Lung cancer; SARS-CoV-2.
Figures
References
- Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, Carrott P, et al. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. Ann Thorac Surg. 2020;110:692–696. doi: 10.1016/j.athoracsur.2020.03.005.
- Nepogodiev D, Bhangu A, Glasbey JC, Li E, Omar OM, Simoes JF, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396:27–38. doi: 10.1016/S0140-6736(20)31182-X.
- Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–704. doi: 10.1016/j.jtho.2020.02.010.
Source: PubMed